Continuous Hemoglobin Evaluation

Evaluate potential sources of error that affect the accuracy of continuous hemoglobin monitoring.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Anemia Hematologic Diseases Hemic and Lymphatic Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

UC Davis Medical Center

Sacramento, California, 95817, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients undergoing elective surgery.

Exclusion criteria

Treatment and study plan

Primary outcomes

Evaluation of the Masimo Continuous Hemoglobin Monitor with Polar Plot Methodology

Time frame: One year

Determine the influence of initial calibration and intraoperative oxygenation variables on the correlation between SpHgb and clinical values

Sponsors and collaborators

Lead sponsor

University of California, Davis

Other

Registry information

Official study title

Evaluation of the Masimo Continuous Hemoglobin Monitor With Polar Plot Methodology

Important dates

Study start: 2012
Primary completion: 2015
Study completion: 2015
First posted: Mar 14, 2013
Registry last updated: Feb 27, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed